Cite
HARVARD Citation
Ramondetta, L. et al. (2017). Beta Adrenergic Blockade Is Feasible During Primary Treatment for Ovarian Cancer [10J]. Obstetrics and gynecology. 129 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ramondetta, L. et al. (2017). Beta Adrenergic Blockade Is Feasible During Primary Treatment for Ovarian Cancer [10J]. Obstetrics and gynecology. 129 (1), p. . [Online].